Web notes  

September 2021
FUNDING OPPORTUNITIES- Back

COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.


NIH Collaborative Program for Multidisciplinary Teams (RM1 Clinical Trial Optional)

Internal deadline: September 7, 2021

This announcement encourages Collaborative Program Grant applications that propose to conduct research to address complex and challenging biomedical problems, important for the mission of the National Institute of General Medical Sciences (NIGMS), through deeply integrated, multidisciplinary research teams. The Grant is designed to support research in which funding a team of interdependent investigators offers significant advantages over support of individual research project grants. Applications should address critical issues and be sufficiently challenging, ambitious, and innovative that objectives could not be achieved by individual investigators. Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations.

Eligibility & Requirements:

Consultation with relevant staff at least 10 weeks prior to the application due date is strongly encouraged.

  • A multiple PD/PI application is required and must include a minimum of 3 and a maximum of 6 PD/PIs who are all necessary to provide sufficient research capacity and the relevant expertise to address the proposed scientific problem.
  • Early Stage Investigators and new investigators who participate as PD/PIs will lose their early stage status for future NIH applications, but ESI leads of pilot studies will not lose ESI status.
  • PD/PIs who have an active NIGMS R35 award can participate as PD/PIs as part of the 51% effort on their current R35 award but may not receive additional funds from this award.
  • Applicants with substantial unrestricted research support may receive funding from this award as their one NIGMS grant award, or may participate in an unfunded advisory or consulting role without loss of their ability to receive one funded NIGMS grant, consistent with NIGMS policies.

Internal Nomination Process:

  1. JHU Limited Submission Cover Sheet
  2. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit)
  3. Curriculum Vitae of investigator, including current external research support and publications
  4. Budget (two pages maximum)
    Questions? Comments? Email the Research Development Team at resapp@jhu.edu.


Inaugural Merkin Peripheral Neuropathy and Nerve Regeneration Center Award

Application submission deadline: September 15, 2021

The Johns Hopkins University School of Medicine announces a request for applications for the inaugural Merkin Peripheral Neuropathy and Nerve Regeneration (PNNR) Center award cycle. The discovery fund award program is designed to attract and support young investigators focused on increasing our understanding of the disease with the ultimate goal of finding new treatment options for peripheral neuropathies and nerve injuries.

This announcement seeks proposals for high-risk, high-reward pilot projects led by junior faculty or senior post-doctoral fellow of the school of medicine. Merkin PNNR Center will award several projects for maximum $50,000/year lasting up to two years depending on the scope of the proposed project. Novelty of the proposed ideas as well as likelihood for successful transitioning to external funding will be the key selection criteria for funding. Duplicate or overlapping funding from any other private or public source for the same project is not allowed. The award recipient or a designee is required to attend the monthly Grant Holders' meeting during the award period. Attendance at minimum 8/12 meetings/year is required to continue to receive funding.

Timeline: Submission deadline by Sep 15, the award announcement by Oct 15 with the expected project start date by Nov 1.

Application package (downloadable from the Merkin PNNR Center website):
The research proposal section (abstract, specific aims, background and significance, preliminary data, methods, data management, and statistical analysis) can be no more than three pages (Arial font size 11). Budget section including the budget justification should not exceed two pages.

  1. General information (proposal title, purpose, strategic reason, summary, total funds requested, institutional approvals, and status of alternative funding.)
  2. Project team information
  3. Proposal (abstract, specific aims, background, significance, and rationale, preliminary results, if applicable, research design and methods, data management plan, statistical plan, project timeline and deliverables.)
  4. Budget (budget period, project years, budget requested/year, and a budget justification section that describes how the funding will be allocated among different budget categories such as personnel, supplies and equipment.) Faculty salary line is not allowed. No indirect costs should be included in the budget.
  5. An NIH-style bio-sketch for the project team that includes all current and pending support from all sponsored and non-sponsored sources.
  6. Letters of support from department/chair/program director/supervisor/mentor are encouraged but not required.

Applications should be submitted to lale.akca@jhu.edu by September 15th.
E-mail Lale Akca for administrative questions.


BOOST and PROPEL Awards

Application deadline: September 20, 2021

BOOST and PROPEL Awards are designed to accelerate protocols to produce efficient, high-quality, safe and disseminatable research. These clinical research grants award ICTR Clinical Research Unit resources to investigators based on merit and willingness to be actively monitored by the Translational Research Evaluation Committee for study-specific milestones.

BOOST Awards - for junior investigators

PROPEL Awards - for established investigators

Any Johns Hopkins University faculty member interested in funding for a new or ongoing clinical research project is eligible to apply.

Review the request for applications or access the application form.

For questions, contact Shernice Madison at smadison@jhu.edu.


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use.


Return to top of Funding Opportunities

 
   
September 2021 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Research Billing Buzz eNewsletter
Coronavirus Research Billing Notices and FAQ
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
Back To School, Safety's Cool!
Johns Hopkins Occupational Health Services
Dual Use Research of Concern (DURC) policies
COVID-19 Funding Opportunities
NIH Collaborative Program for Multidisciplinary Teams (RM1 Clinical Trial Optional)
Inaugural Merkin Peripheral Neuropathy and Nerve Regeneration Center Award
BOOST and PROPEL Awards
Michael J. Fox Foundation (MJFF) Challenge
Updated Guidance from NIH on COVID-19 Flexibilities for Applicants and Recipients
COVID-19 and Research Updates
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for September, October and November

Updated Events at the Genetics Research Core Facilities
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center